Valuation: RAMM Pharma Corp.

Market Cap 1.19M 846K 744K 692K 636K 81.13M 1.21M 8.23M 3.21M 40.06M 3.18M 3.11M 138M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 333K 293K 273K 251K 31.97M 477K 3.24M 1.27M 15.78M 1.25M 1.22M 54.56M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2019-09-30
Director of Finance/CFO - 2022-12-08
Director TitleAgeSince
Director/Board Member - 2019-09-30
Director/Board Member 82 2019-09-30
Director/Board Member 66 2019-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-76.29%-92.33% - - 846K
+1.61%+3.90%+51.12%+166.36% 1,068B
+1.29%+7.91%+62.70%+55.00% 641B
+3.13%+3.44%+40.52%+75.61% 454B
+2.25%+10.31%+41.29%+36.67% 351B
+1.62%+4.03%+39.92%+44.71% 299B
+0.59%+3.79%+20.17%+17.25% 266B
+2.73%+3.50%-25.66%-36.53% 220B
+4.25%+7.36%+30.50%+66.34% 203B
+2.49%+2.70%+18.38%+74.08% 162B
Average -5.64%+2.76%+30.99%+55.50% 407.04B
Weighted average by Cap. +1.94%+2.85%+40.53%+80.66%

Financials

2024 2025
Net sales 4.34M 3.08M 2.7M 2.52M 2.31M 295M 4.4M 29.93M 11.69M 146M 11.55M 11.3M 504M 3.36M 2.38M 2.09M 1.95M 1.79M 228M 3.4M 23.16M 9.05M 113M 8.94M 8.75M 390M
Net income -16.5M -11.69M -10.28M -9.57M -8.79M -1.12B -16.72M -114M -44.42M -554M -43.9M -42.95M -1.91B -8.91M -6.31M -5.55M -5.17M -4.75M -605M -9.03M -61.41M -23.99M -299M -23.7M -23.19M -1.03B
Net Debt -626K -443K -390K -363K -333K -42.52M -634K -4.31M -1.68M -21M -1.66M -1.63M -72.57M -723K -513K -451K -420K -385K -49.17M -733K -4.99M -1.95M -24.28M -1.92M -1.88M -83.91M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-